Opinion

Video

AYA ALL: Overview and Risk Stratification

Author(s):

Michael R. Grunwald, MD, FACP,Kelly Weaver, NP, DNP

Experts on acute lymphoblastic leukemia share their clinical experiences, describe high-risk features, and provide insights on risk stratification practices.

Video content above is prompted by the following questions:

  • How is ALL risk stratified?
    • Which patient risk factors are considered?
    • Is there one standard model used?
    • What defines low-standard risk vs high risk?

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest CME

View All
Expert Perspectives on Applying Recent Evidence to Practice in the Management of Newly Diagnosed Multiple Myeloma
Video

Expert Perspectives on Applying Recent Evidence to Practice in the Management of Newly Diagnosed Multiple Myeloma

Jun 19th 2025 - Jul 25th 2025

online-activity
View More
Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies
Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies

Jun 18th 2025 - Jun 19th 2026

online-activity
View More
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
View More
Related Content
The top 5 OncLive videos of the week cover insights in CLL, multiple myeloma, follicular lymphoma, and extrapulmonary neuroendocrine carcinomas.
June 22nd 2025

Five Under 5: Top Oncology Videos for the Week of 6/15

Chandler Park, MD, medical oncologist, Norton Cancer Institute; Ann S. LaCasce, MD, MMSc, associate professor, medicine, lymphoma specialist, Dana-Farber Cancer Institute, Director, Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology
March 26th 2025

Strong Mentorship Opportunities Support the Next Generations of Women in Lymphoma: With Chandler Park, MD; and Ann S. LaCasce, MD, MMSc

Hematological Malignancies | Image credit: © Om.Nom.Nom - stock.adobe.com
June 20th 2025

UM171 Cell Therapy Earns Positive CHMP Opinion for Hematological Malignancies

Paul J. Shaughnessy, MD, medical director, Adult Blood and Marrow Stem Cell Transplant Program, Methodist Hospital
November 28th 2024

FDA Approval Insights: Obe-Cel in B-Cell Precursor ALL

Galleri Multicancer Early Detection Test : © Bipul Kumar - stock.adobe.com
June 19th 2025

PATHFINDER 2 Trial Releases Positive Topline Data for Multicancer Early Detection Test

R/R Hematologic Malignancies | Image credit: © Om.Nom.Nom - stock.adobe.com
June 18th 2025

FDA Grants Orphan Drug Designation to SENTI-202 for R/R AML and Hematologic Malignancies